Decreased CP-1 (NF-Y) activity results in transcriptional down-regulation of topoisomerase IIα in a doxorubicin-resistant variant of human multiple myeloma RPMI 8226

Biochemical and Biophysical Research Communications

Volumn 237, Issue 2, 1997, Pages 217-224

  Wang, Hong ^a   Jiang, Zhi Gang ^a   Wong, Yee W ^a   Dalton, William S ^b   Futscher, Bernard W ^b   Chan, Victor T W ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROMOTER REGION; SOUTHERN BLOTTING;

EID: 0031577472     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1997.7115     Document Type: Article

References (27)

1. Wang J. C. Biochim. Biophys. Acta. 909:1987;1-9.
2. Tsui-Pflugfflder M., Liu L. F., Tewey K. M., Whang-Peng J., Kuntsen T., Heubner K., Croce C. M., Wang J. C. Proc. Natl. Acad. Sci. USA. 85:1988;7177-7718.
3. Chung T. D. Y., Drake F. H., Tan K. B., Per S. R., Crooke S. T., Mirabelli C. K. Proc. Natl. Acad. Sci. USA. 86:1989;9431-9435.
4. Woessner R. D., Mattern M. R., Mirabelli C. K., Johnson R. K., Drake F. H. Cell Growth Differ. 2:1991;209-214.
5. Gasser S. M., Laroche T., Falquet J., Boy de la Tour E., Laemmli U. K. J. Mol. Biol. 188:1986;613-629.
6. Liu L. F. Annu. Rev. Biochem. 58:1989;351-375.
7. Bugg B. Y., Danks M. K., Beck W. T., Suttle D. P. Proc. Natl. Acad. Sci. USA. 88:1991;7654-7658.
8. Chan V. T. W., Ng S. W., Eder J. P., Schnipper L. E. J. Biol. Chem. 268:1993;2160-2165.
9. Hinds M., Deisseroth K., Mayes J., Altschuler E., Jansen R., Ledley F. D., Zwelling L. A. Cancer Res. 51:1991;4729-4731.
10. Pommier Y., Kerrigan D., Schwartz R. E., Swack J. A., McCurdy A. Cancer Res. 46:1986;3075-3081.
11. Tan K. B., Mattern M. R., Eng W. K., McCabe F. l., Johnson R. K. J.N.C.I. 81:1989;1732-1735.
12. Webb C. D., Latham M. D., Lock R. B., Sullivan D. M. Cancer Res. 51:1991;6543-6549.
13. Feldhoff P. W., Mirski S. E., Cole S. P., Sullivan D. M. Cancer Res. 54:1994;756-762.
14. Kubo T., Kohno K., Ohga T., Taniguchi K., Kawanami K., Wada M., Kuwano M. Cancer Res. 55:1995;3860-3864.
15. Hochhauser D., Stanway C. A., Harris A. L., Hickson I. D. J. Biol. Chem. 267:1992;18961-18965.
16. Ng S. W., Eder J. P., Schnipper L. E., Chan V. T. W. J. Biol. Chem. 270:1995;25850-25858.
17. Isaacs R. J., Harris A. L., Hickson I. D. J. Biol. Chem. 271:1996;16741-16747.
18. Goswami P. C., Roti Roti J. L., Hunt C. R. Mol. Cell. Biol. 16:1996;1500-1508.
19. Futscher B. W., Foley N., Gleason-Guzman M., Meltzer P. S., Sullivan D. M., Dalton W. S. Int'l. J. Cancer. 66:1996;520-525.
20. Danks M. K., Warmoth M. R., Friche E., Granzen B., Bugg B. Y., Harker W. G., Zwelling L. A., Futscher B. W., Suttle D. P., Beck W. T. Cancer Res. 53:1993;1373-1379.
21. Sullivan D. M., Latham M. D., Rowe T. C., Ross W. E. Biochemistry. 28:1989;5680-5687.
22. Arcot S. S., Deininger P. L. Gene. 111:1992;249-254.
23. Ronchi A., Bellorini M., Mongelli N., Mantovani R. Nucleic Acids Res. 23:1995;4565-4572.
24. Milo P. M., Zaret K. S. Gene Development. 6:1992;991-1004.
25. Eder J. P., Teicher B. A., Holden S. A., Cathcart K. N. S., Schnipper L. E. Cancer Chemother. Pharmacol. 26:1990;423-428.
26. DeJone S., Timmer-Bosscha H., DeVries E., Mulder N. H. Int'l. J. Cancer. 53:1993;110-117.
27. Eder J. P. Jr., Chan V. T. W., Ng S. W., Rizvi N. A., Zacharoulis S., Teicher B. A., Schnipper L. E. Cancer Res. 55:1995;6109-6116.